[1]
Stefanini GG, Byrne RA, Windecker S, Kastrati A. State of the art: coronary artery stents - past, present and future. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2017 Aug 25:13(6):706-716. doi: 10.4244/EIJ-D-17-00557. Epub
[PubMed PMID: 28844032]
[2]
Barton M, Grüntzig J, Husmann M, Rösch J. Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985). Frontiers in cardiovascular medicine. 2014:1():15. doi: 10.3389/fcvm.2014.00015. Epub 2014 Dec 29
[PubMed PMID: 26664865]
[3]
Kostić J, Beleslin B, Nedeljković M, Ostojić M. [Pioneers of invasive cardiovascular medicine--Charles Theodore Dotter and colleagues: short historical review]. Srpski arhiv za celokupno lekarstvo. 2014 Jan-Feb:142(1-2):131-7
[PubMed PMID: 24684046]
[4]
Tan C, Schatz RA. The History of Coronary Stenting. Interventional cardiology clinics. 2016 Jul:5(3):271-280. doi: 10.1016/j.iccl.2016.03.001. Epub 2016 Jun 21
[PubMed PMID: 28582026]
[5]
Varenhorst C, Lindholm M, Sarno G, Olivecrona G, Jensen U, Nilsson J, Carlsson J, James S, Lagerqvist B. Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents. Clinical research in cardiology : official journal of the German Cardiac Society. 2018 Sep:107(9):816-823. doi: 10.1007/s00392-018-1252-0. Epub 2018 Apr 17
[PubMed PMID: 29667015]
[6]
Kereiakes DJ, Cannon LA, Dauber I, Ball M, Bertolet B, Foster M, Nersesov AY, Underwood PL, Allocco DJ, Dawkins KD. Long-term follow-up of the platinum chromium TAXUS Element (ION) stent: The PERSEUS Workhorse and Small Vessel trial five-year results. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2015 Nov 15:86(6):994-1001. doi: 10.1002/ccd.25877. Epub 2015 Feb 25
[PubMed PMID: 25678402]
[7]
Kedhi E, Stone GW, Kereiakes DJ, Serruys PW, Parise H, Fahy M, Simonton CA, Sudhir K, Sood P, Smits PC. Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2012 Sep:8(5):599-606. doi: 10.4244/EIJV8I5A92. Epub
[PubMed PMID: 22995087]
[8]
de Ribamar Costa J Jr, Abizaid A, Bartorelli AL, Whitbourn R, Jepson N, Perin M, Steinwender C, Stuteville M, Ediebah D, Sudhir K, Serruys PW. One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2016 Nov 20:12(10):1255-1262. doi: 10.4244/EIJV12I10A206. Epub
[PubMed PMID: 27866134]
Level 2 (mid-level) evidence
[9]
Doros G, Massaro JM, Kandzari DE, Waksman R, Koolen JJ, Cutlip DE, Mauri L. Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach. American heart journal. 2017 Nov:193():35-45. doi: 10.1016/j.ahj.2017.08.001. Epub 2017 Aug 5
[PubMed PMID: 29129253]
Level 2 (mid-level) evidence
[10]
Kandzari DE, Mauri L, Koolen JJ, Massaro JM, Doros G, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE, Waksman R, BIOFLOW V Investigators. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. Lancet (London, England). 2017 Oct 21:390(10105):1843-1852. doi: 10.1016/S0140-6736(17)32249-3. Epub 2017 Aug 26
[PubMed PMID: 28851504]
Level 1 (high-level) evidence
[11]
Kereiakes DJ, Meredith IT, Masotti M, Carrié D, Moreno R, Erglis A, Mehta SR, Elhadad S, Berland J, Stein B, Airaksinen J, Jobe RL, Reitman A, Janssens L, Christen T, Dawkins KD, Windecker S. Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2017 Mar 20:12(16):1987-1994. doi: 10.4244/EIJ-D-16-00643. Epub
[PubMed PMID: 27840326]
[12]
Kereiakes DJ, Meredith IT, Windecker S, Lee Jobe R, Mehta SR, Sarembock IJ, Feldman RL, Stein B, Dubois C, Grady T, Saito S, Kimura T, Christen T, Allocco DJ, Dawkins KD. Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial. Circulation. Cardiovascular interventions. 2015 Apr:8(4):. pii: e002372. doi: 10.1161/CIRCINTERVENTIONS.114.002372. Epub
[PubMed PMID: 25855680]
Level 1 (high-level) evidence
[13]
Konishi A, Ho M, Shirai Y, Shirato H. First Approval of Improved Medical Device Conditional on Use-Result Survey in Japan - Regulatory Review of Polymer-Free Drug-Coated BioFreedom Coronary Stent. Circulation journal : official journal of the Japanese Circulation Society. 2018 May 25:82(6):1487-1490. doi: 10.1253/circj.CJ-17-1425. Epub 2018 Mar 21
[PubMed PMID: 29563353]
Level 3 (low-level) evidence
[14]
Waksman R, Piegari GN, Kabour A, Cannon L, Wang J, Adams G, Solankhi N, Smeglin A, Kereiakes DJ, Leiboff R, Spad MA, Torguson R, Chandra N, Bastian R, DeGroot J, Kayo MW, Stoll HP, Garcia-Garcia HM. Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial. Cardiovascular revascularization medicine : including molecular interventions. 2017 Oct-Nov:18(7):475-481. doi: 10.1016/j.carrev.2017.07.017. Epub 2017 Jul 31
[PubMed PMID: 28923692]
[15]
Garot P, Morice MC, Tresukosol D, Pocock SJ, Meredith IT, Abizaid A, Carrié D, Naber C, Iñiguez A, Talwar S, Menown IBA, Christiansen EH, Gregson J, Copt S, Hovasse T, Lurz P, Maillard L, Krackhardt F, Ong P, Byrne J, Redwood S, Windhövel U, Greene S, Stoll HP, Urban P, LEADERS FREE Investigators. 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents. Journal of the American College of Cardiology. 2017 Jan 17:69(2):162-171. doi: 10.1016/j.jacc.2016.10.009. Epub 2016 Oct 30
[PubMed PMID: 27806919]
[16]
Pavasini R, Serenelli M, Gallo F, Bugani G, Geraci S, Vicinelli P, Campo G. Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials. Journal of thoracic disease. 2017 Aug:9(Suppl 9):S887-S897. doi: 10.21037/jtd.2017.06.59. Epub
[PubMed PMID: 28894594]
Level 1 (high-level) evidence
[17]
de Hemptinne Q, Picard F, Ly HQ, Ibrahim R, Asgar AW, de Guise P, Doucet S, Dorval JF, Marquis-Gravel G, Levi M, L-L'allier P, Tanguay JF. Long-term outcomes of bioresorbable vascular scaffold in ST-elevation myocardial infarction. Acta cardiologica. 2018 Jun:73(3):276-281. doi: 10.1080/00015385.2017.1380767. Epub 2017 Sep 28
[PubMed PMID: 28954592]
[18]
Worthley SG, Abizaid A, Kirtane AJ, Simon DI, Windecker S, Brar S, Meredith IT, Shetty S, Sinhal A, Almonacid AP, Chamié D, Maehara A, Stone GW, RevElution Investigators. First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study. JACC. Cardiovascular interventions. 2017 Jan 23:10(2):147-156. doi: 10.1016/j.jcin.2016.10.020. Epub
[PubMed PMID: 28104208]
Level 2 (mid-level) evidence
[19]
Akbar H, Foth C, Kahloon RA, Mountfort S. Acute ST-Elevation Myocardial Infarction. StatPearls. 2023 Jan:():
[PubMed PMID: 30335314]
[20]
Collet C, Grundeken MJ, Asano T, Onuma Y, Wijns W, Serruys PW. State of the art: coronary angiography. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2017 Aug 25:13(6):634-643. doi: 10.4244/EIJ-D-17-00465. Epub
[PubMed PMID: 28844026]
[21]
Shlofmitz E, Shlofmitz R, Lee MS. Orbital Atherectomy: A Comprehensive Review. Interventional cardiology clinics. 2019 Apr:8(2):161-171. doi: 10.1016/j.iccl.2018.11.006. Epub 2019 Jan 30
[PubMed PMID: 30832940]
[22]
Allen DW, Kaul P. Atherectomy and Specialty Balloons in Percutaneous Coronary Intervention. Current treatment options in cardiovascular medicine. 2019 Mar 4:21(3):13. doi: 10.1007/s11936-019-0717-4. Epub 2019 Mar 4
[PubMed PMID: 30830449]